Marc A. Cohen - Oct 4, 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/S/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Oct 4, 2021
Transactions value $
$20,740
Form type
4
Date filed
10/5/2021, 04:55 PM
Previous filing
Jul 7, 2021
Next filing
Jan 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Award $20.7K +461 $44.99 461 Oct 4, 2021 Direct F1, F2, F3
holding CCCC Common Stock 1.97M Oct 4, 2021 By March Andrew Cohen Revocable Trust F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 4, 2021.
F3 This amount has been adjusted to reflect 6,641 shares previously transferred from the Reporting Person to the Marc Andrew Cohen Revocable Trust.
F4 Shares held by Reporting Person as trustee of the Marc Andrew Cohen Revocable Trust.